Last reviewed · How we verify
Balanced Gelatin Solution
At a glance
| Generic name | Balanced Gelatin Solution |
|---|---|
| Also known as | Succinylated Gelatin 4%, Gelatin Infusion, Gelaspan |
| Sponsor | Shanghai Zhongshan Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Gelaspan vs Crystalloid Therapy in Sepsis (PHASE4)
- Gelatin in ICU and Sepsis (PHASE4)
- Biomarker-guided Intervention to Prevent Acute Kidney Injury (NA)
- Impact of Balanced Crystalloid and Colloid Infusion on Haemostasis in Healthy Male Volunteers (NA)
- Biomarker-guided Implementation of the AKI Bundle (NA)
- Study on the Efficacy and Safety of Gelaspan (PHASE3)
- Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug (PHASE1)
- A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Balanced Gelatin Solution CI brief — competitive landscape report
- Balanced Gelatin Solution updates RSS · CI watch RSS
- Shanghai Zhongshan Hospital portfolio CI